Delta-Fly Pharma, Inc. announced that it expects to receive Ñ1.300842 billion in funding from Macquarie Group Limited

Delta-Fly Pharma, Inc. announced a private placement of unsecured bonds for an aggregate gross proceeds of Ñ1,300,842,000 on November 17, 2022. The transaction included participation from Macquarie Group Limited. The transaction has been approved by the board of directors of the company.